IGM Biosciences Announces Worldwide Collaboration Agreement With Sanofi To Create And Develop IgM Agonist Antibodies Will Focus Exclusively On Immunology/Inflammation Targets
IGM Biosciences Announces Worldwide Collaboration Agreement With Sanofi To Create And Develop IgM Agonist Antibodies Will Focus Exclusively On Immunology/Inflammation Targets
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.